(Q33734164)

29 July 2017

Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy (English)

1 reference

demyelinating polyneuropathy

29 July 2017

1 reference

E Bertini

7

0 references

author name string

M Sabatelli

1

1 reference

29 July 2017

T Mignogna

2

1 reference

29 July 2017

G Lippi

3

1 reference

29 July 2017

M Milone

4

1 reference

29 July 2017

V Di Lazzaro

5

1 reference

29 July 2017

P Tonali

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

29 July 2017

1 reference

29 July 2017

58

1 reference

29 July 2017

5

1 reference

29 July 2017

638-639

1 reference

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073503

PubMed Central

reference URL

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073503

PubMed Central

reference URL

[Interferon alpha and autoimmunity]

21 June 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/7745420

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP.58.5.638

1 reference

29 July 2017

1 reference

29 July 2017

1 reference